Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.72%
#2 Ocean Protocol Ocean Protocol +16.45%
#3 Cysic Cysic +16.43%
#4 KUB Coin KUB Coin +15.39%
#5 Audiera Audiera +10.87%
#6 Geodnet Geodnet +10.71%
#7 Quack AI Quack AI +10.35%
#8 Perle Perle +10.31%
#9 Tutorial Tutorial +10.22%
#10 Arowana Arowana +10.11%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
सेटिंग्स
भाषा
हिन्दी
मुद्रा
USD
थीम
CytoMed Therapeutics Limited CytoMed Therapeutics Limited

CytoMed Therapeutics Limited

GDTC
शेयरों में रैंक #32324
CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical... CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical development phase, founded in 2018 and based in Singapore. The firm specializes in creating advanced cellular immunotherapies aimed at combating various human malignancies. Its primary investigational product, CTM-N2D, involves cultivated gamma delta T cells that are engineered with a chimeric antigen receptor (CAR) specifically targeting natural killer group 2D ligands, designed to boost their capacity to destroy cancer cells. Beyond its lead candidate, CytoMed is also advancing iPSC-gdNKT, which utilizes induced pluripotent stem cells (iPSCs) to generate a novel hybrid cell combining properties of both gamma delta T cells and natural killer cells. Additionally, the company is developing CTM-GDT, an immunotherapy consisting of expanded gamma delta T cells that leverages their innate, broad-spectrum recognition system to identify and address diverse cancer types.
शेयर मूल्य
$0.88
अंतिम समन्वयन: 2026-08-17
मार्केट कैप
$10.41M
बदलाव (1 दिन)
-7.26%
बदलाव (1 वर्ष)
-50.56%
देश
SG
व्यापार CytoMed Therapeutics Limited (GDTC)

श्रेणी

Healthcare
CytoMed Therapeutics Limited (GDTC) के लिए P/B अनुपात
2026 को P/B अनुपात TTM: 0
CytoMed Therapeutics Limited की नवीनतम वित्तीय रिपोर्ट और शेयर मूल्य के अनुसार, कंपनी का वर्तमान P/B अनुपात (TTM) 0 है। 2026 के अंत में, कंपनी का P/B अनुपात 0 था।
CytoMed Therapeutics Limited के लिए 2026 से 2026 तक P/B अनुपात का इतिहास
हर वर्ष के अंत में P/B अनुपात
वर्ष P/B अनुपात परिवर्तन
प्रदान की गई तारीखों के लिए पर्याप्त डेटा नहीं।
समान कंपनियों या प्रतिस्पर्धियों के लिए P/B अनुपात
कंपनी P/B अनुपात P/B अनुपात में अंतर देश
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR